Researchers hunt for clues to prevent dangerous clots in rare blood cancer

NCT ID NCT05548062

Ongoing Knowledge-focused Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study watches 242 adults with high-risk polycythemia vera (a rare blood cancer that thickens the blood) who have already had a blood clot. Researchers track health data like blood pressure, weight, and lab tests to see which factors best predict future clots. The goal is to help doctors identify who is most at risk and improve prevention strategies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired polycythemia vera

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POLYCYTHEMIA VERA

Contacts and locations

Locations

Novartis Investigative Site

Alessandria, AL, 15121, Italy
Novartis Investigative Site

Ancona, AN, 60126, Italy
Novartis Investigative Site

Bari, BA, 70124, Italy
Novartis Investigative Site

Bologna, BO, 40138, Italy
Novartis Investigative Site

Como, CO, 22100, Italy
Novartis Investigative Site

Cosenza, CS, 87100, Italy
Novartis Investigative Site

Catania, CT, 95123, Italy
Novartis Investigative Site

Florence, FI, 50134, Italy
Novartis Investigative Site

Genova, GE, 16132, Italy
Novartis Investigative Site

Lecce, LE, 73100, Italy
Novartis Investigative Site

Tricase, LE, 73039, Italy
Novartis Investigative Site

Monza, MB, 20900, Italy
Novartis Investigative Site

Milan, MI, 20122, Italy
Novartis Investigative Site

Palermo, PA, 90127, Italy
Novartis Investigative Site

Palermo, PA, 90146, Italy
Novartis Investigative Site

Piacenza, PC, 29121, Italy
Novartis Investigative Site

Padova, PD, 35128, Italy
Novartis Investigative Site

Pisa, PI, 56126, Italy
Novartis Investigative Site

Parma, PR, 43126, Italy
Novartis Investigative Site

Reggio Calabria, RC, 89124, Italy
Novartis Investigative Site

Reggio Emilia, RE, 42123, Italy
Novartis Investigative Site

Roma, RM, 00161, Italy
Novartis Investigative Site

Roma, RM, 00168, Italy
Novartis Investigative Site

Roma, RM, 00189, Italy
Novartis Investigative Site

Pagani, SA, 84016, Italy
Novartis Investigative Site

Orbassano, TO, 10043, Italy
Novartis Investigative Site

Torino, TO, 10126, Italy
Novartis Investigative Site

Terni, TR, 05100, Italy
Novartis Investigative Site

Varese, VA, 21100, Italy
Novartis Investigative Site

Vicenza, VI, 36100, Italy
Novartis Investigative Site

Verona, VR, 37134, Italy
Novartis Investigative Site

Viterbo, VT, 01033, Italy
Novartis Investigative Site

Naples, 80131, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.